(Q37280136)

English

Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells

scientific article published on 07 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Rafaela Erices

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Maria Loreto Bravo

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Pamela Gonzalez

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Bárbara Oliva

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Dusan Racordon

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Marcelo Garrido

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Carolina Ibañez

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sumie Kato

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jorge Brañes

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Javier Pizarro

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Maria Isabel Barriga

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Alejandro Barra

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Erasmo Bravo

13

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Catalina Alonso

14

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Eva Bustamente

15

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Mauricio A Cuello

16

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Gareth I Owen

17

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

7 May 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Reproductive Sciences

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1433-1446

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin as an antitumor agent in cancer prevention and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Understanding the benefit of metformin use in cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Establishment of a database of metformin plasma concentrations and erythrocyte levels in normal and emergency situations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin and cancer: new applications for an old drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

The biology of ovarian cancer: new opportunities for translation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Treating prediabetes with metformin: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Pegylated liposomal doxorubicin in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Metformin and reduced risk of cancer in diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

6 September 2017

Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

14 September 2017

Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

14 September 2017

Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

14 September 2017

The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

14 September 2017

Cell cycle dependent antagonistic interactions between paclitaxel and carboplatin in combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

14 September 2017

TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

14 September 2017

Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

3 September 2018

Effect of metformin on insulin sensitivity and insulin secretion in female obese patients with normal glucose tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

3 September 2018

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

3 September 2018

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3817664

3 September 2018

Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin and 5-fluorouracil plasma concentrations and detectability in parotid saliva

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1933719113488441

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37280136&oldid=1727105076"